ARCH Venture Fund X, L.P. is 10% Owner at Sana Biotechnology, Inc. (SANA). They have made 1 open-market trade across 1 company since 2024, most recently 2024-02-08.
CIK 0001757011
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.0M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SANA | 10,667,387 | $24.3M |
Shares reported on the most recent Form 4, priced at the 2024-02-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SANA | BUY | 2024-02-08 | 2024-02-12 | $5.50 | $2.0M | +27.7% | +51.8% | +21.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.